01—History
Long-Term Debt History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $374.8M
1 older move runs past ±150% (largest +5953.3%); point at, tap or drag across the bars to read one.
02—Ledger
Long-Term Debt, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $374.8M | −16.7% | 10-K | |
| FY2024 | $449.8M | −27.8% | 10-K | |
| FY2023 | $622.9M | −10.3% | 10-K | |
| FY2022 | $694.4M | −10.4% | 10-K | |
| FY2021 | $775.2M | −9.7% | 10-K | |
| FY2020 | $858.5M | +22.7% | 10-K | |
| FY2019 | $699.4M | +16.2% | 10-K | |
| FY2018 | $601.8M | −0.8% | 10-K | |
| FY2017 | $606.6M | +2.2% | 10-K | |
| FY2016 | $593.7M | −0.6% | 10-K | |
| FY2015 | $597.1M | +70.6% | 10-K | |
| FY2014 | $350.0M | +131.2% | 10-K | |
| FY2013 | $151.4M | +5953.3% | 10-K | |
| FY2012 | $2.5M | −26.8% | 10-K | |
| FY2011 | $3.4M | — | 10-K |
03—Questions
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is IDEXX Laboratories's current long-term debt?
IDEXX Laboratories (IDXX) annual long-term debt for 2025 was $374.8M, a 16.66% decline from 2024. IDEXX Laboratories long-term debt for the quarter ending September 30, 2026 was $299.9M.
What was IDEXX Laboratories's long-term debt in 2024?
IDEXX Laboratories annual long-term debt for 2024 was $449.8M, a 27.79% decline from 2023.
What was IDEXX Laboratories's long-term debt in 2023?
IDEXX Laboratories annual long-term debt for 2023 was $622.9M, a 10.30% decline from 2022.
What is IDEXX Laboratories's 5-year long-term debt CAGR?
IDEXX Laboratories long-term debt grew at a compound annual growth rate (CAGR) of 15.27% from FY2020 to FY2025, going from $858.5M to $374.8M over 5 years.
- Company
- IDEXX Laboratories
- Ticker
- IDXX
- Sector
- Other
- Industry
- In Vitro & In Vivo Diagnostic Substances